- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | CA72-4 Gastric Cancer Marker CLIA Kit |
| Catalog No. | TMTR-HMM-0068 |
| Description | A chemiluminescence immunoassay kit for the quantitative detection of CA72-4 (TAG-72 antigen) in human serum, serving as a tumor marker for gastric carcinoma and other mucin-producing adenocarcinomas. |
| Intended Use | Quantitative CA72-4 measurement for monitoring gastric cancer patients and as an adjunct marker in other adenocarcinomas. |
| Principle / Technology | Sandwich CLIA with two monoclonal antibodies (B72.3 and CC49) recognizing distinct epitopes on the TAG-72 tumor-associated glycoprotein. |
| Detection Method | Automated chemiluminescence detection |
| Sample Type | Human serum |
| Performance Range / Specifications | 0.5–300 U/mL |
| Sensitivity / LOD | ≤0.3 U/mL |
| Specificity | Dual monoclonal design ensures specific TAG-72 recognition; no interference from CA125, CA19-9, or CEA |
| Reaction Conditions / Protocol | Automated 20-minute incubation protocol |
| Components / Formulation | Magnetic particle reagent, acridinium ester-labeled antibody, calibrator set, quality control materials |
| Storage Conditions | 2–8°C |
| Shelf Life | 18 months |
| Package Specifications | 100 tests |
| Product Form | Ready-to-use liquid reagents |
| Quality Control | Calibrators traceable to internal reference; inter-assay CV below 5% |
| Key Features | Specific gastric cancer marker complementing CEA and CA19-9 panels; automated format integrated into laboratory workflow |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagnoTech. All rights reserved.
